|
|
||||||||
Diabetes Pharmacology Unit, Novartis Pharmaceuticals Corporation, Summit, New Jersey 07901
A lactate clamp method has been developed to
quantify the whole body lactate utilization in conscious, unstressed
rats. Dichloroacetate (DCA), a known lactate utilization enhancer, was
used to validate the method. Fasting blood lactate concentrations
before the clamps were identical for DCA-treated (1 mmol/kg) and
control groups (1.65 ± 0.37 vs. 1.65 ± 0.19 mM). The animals
received a primed continuous lactate infusion for 90 min at variable
rates to clamp the blood lactate concentration at 2 mM. The
steady-state (60-90 min) lactate infusion rate, which represents
the whole body lactate utilization in DCA-treated animals, was 144%
higher than that in the control animals (13.2 ± 1.0 vs. 5.4 ± 1.1 mg · kg
1 · min
1;
P < 0.001). The markedly increased
lactate infusion rate indicates an enhanced lactate flux by DCA. To
determine whether the increased lactate infusion by DCA reflected
reduced endogenous lactate production, lactate production was measured.
The results indicate that endogenous lactate production was not
affected by DCA. In conclusion, the lactate clamp provides a sensitive
and reliable method to assess lactate utilization in vivo, a dynamic
measurement that may not be clearly demonstrated by blood lactate
concentrations per se.
lactate infusion; lactate production; dichloroacetate
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |